Web-based Genetic Research on Parkinson's Disease

Ongoing, Web-Based Genome-Wide Association Studies for Targeted Disease Initiatives

The purpose of this study is to examine how genes and environment affect risk for Parkinson's disease.

23andMe has created a web-based Parkinson's research initiative to understand the genetic associations found between Parkinson's patients' DNA and their disease. To learn more, visit: https://www.23andme.com/pd/. You can participate in this research initiative without leaving home. If you are eligible to participate, we will send you an in-home 23andMe DNA kit at no cost. We will ask you short online surveys (15-20) about your Parkinson's journey, symptoms, and response to treatment. Enrollment is on-going and open to individuals who have been diagnosed with Parkinson's disease and are residents of the U.S. Participants receive access to ancestry information and uninterpreted genetic data. Participants will also receive regular updates on our research efforts and findings.

Inclusion Criteria:

• diagnosis of Parkinson's disease by a physician

Exclusion Criteria:

• diagnoses other than Parkinson's, including:
• progressive supranuclear palsy (PSP)
• multiple system atrophy (MSA)
• Shy-Drager syndrome
• spinal cerebella ataxia (SCA)
• atypical parkinsonism
• parkinsonism due to medications, drug-induced parkinsonism
• vascular parkinsonism
• frontotemporal dementia with parkinsonism